The News Review:
- » Clinical Research
- A New Year’s Resolution for the FDA: Kick the Drug (Company) Addiction
- Ranbaxy’s NDDR team achieves landmark in GSK research prog
- Howard Feldman Joins Bristol-Myers Squibb as Vice President and …
- A spotlight on the professions
- McGill MUHC and Douglas researchers get top marks from Québec Science
- Phoenix conference highlights TGen’s and Scottsdale Healthcare’s …
» Clinical Research
Hays Pharma UK
Successful candidates will not only have exposure to the widest range of clinical research opportunities available in the industry but also be offered world class training and employee development. Additional responsibilities of this role compriseSite selection initiation monitoring and close-out visits in accordance with contracted scope of work and good clinical practice.
A New Year’s Resolution for the FDA: Kick the Drug (Company) Addiction
Huffington Post NY
Wood MB a former assistant vice chancellor for clinical research and associate dean at Vanderbilt Medical School is currently the Managing Director of Symphony Capital LLC a private equity company that invests in biopharmaceuticals. He has served as a director of pharmaceutical companies; has provided Congressional testimony and has advised senior White House officials legislators and the Secretary of Health. Why recommend him over Nissen or Califf who we believe are too close to industry? Wood’s track record sets him apart. A former member of various editorial boards including The New England Journal of Medicine Wood was the chair of the 2005 FDA Advisory Committee that pushed the FDA to remove Vioxx and a related drug from the market.
Ranbaxy’s NDDR team achieves landmark in GSK research prog
Moneycontrol.com India
js’> Commenting on this significant achievement Dr. Sudershan Arora President Drug Development and Clinical Research Ranbaxy said “Ranbaxy’s development team has the capability to conduct clinical studies on NCEs and is looking forward to advancing this lead compound through to Proof of Concept studies. Pradip Bhatnagar Sr. VP of Drug Discovery Research stated “My team and I are elated with this achievement.
Howard Feldman Joins Bristol-Myers Squibb as Vice President and …
MarketWatch (press release)
Howard Feldman has joined the company’s Research and Development organization as vice president and therapeutic area head Global Clinical Research Neuroscience. He will report to Dr. Doug Manion vice president Global Clinical Research Neuroscience and Virology. “I am pleased Howard has joined our R&D organization as we look to further build our robust pipeline in areas of significant unmet medical need in neuroscience” said Brian Daniels M. Senior Vice President Global Development & Medical Affairs.
A spotlight on the professions
Boston Globe United States
Clinical Research pen House. Program will introduce course offerings roles within clinical research and job opportunities. Meets from 6 to 8 p.
McGill MUHC and Douglas researchers get top marks from Québec Science
McGill University Health Center Canada
About the Research Institute of the MUHCThe Research Institute of the McGill University Health Centre(RI MUHC) is a world-renowned biomedical and health-care hospitalresearch centre. Located in Montreal Quebec the institute is theresearch arm of the MUHC the university health center affiliatedwith the Faculty of Medicine at McGill University. The institutesupports over 600 researchers nearly 1200 graduate andpost-doctoral students and operates more than 300 laboratoriesdevoted to a broad spectrum of fundamental and clinical research. The Research Institute operates at the forefront of knowledgeinnovation and technology and is inextricably linked to theclinical programs of the MUHC ensuring that patients benefitdirectly from the latest research-based knowledge. The Research Institute of the MUHC is supported in part by theFonds de la recherche en santé du Québec. For further detailsvisit:.
Phoenix conference highlights TGen’s and Scottsdale Healthcare’s …
Genetic Engineering News (press release) NY
“Given the explosion of new information on the genetic and cellular features of malignancy the modern oncologist must master the significance and application of cancer-related sciences” said Dr. Ramanathan Medical Director of TGen Clinical Research Services at Scottsdale Healthcare a partnership between TGen and Scottsdale Healthcare Corp. Beyond the five vital signs of pulse respiration temperature blood pressure and pain is a new sixth vital sign molecular therapeutics. This is the ability to identify the causes of disease at the molecular level in order to provide the right drugs in the right amounts at the right times for the specific needs of individual patients; what is becoming better known in health circles as personalized medicine. “This gap in knowledge and its application in clinical practice will be addressed in this conference” said Dr. Ramanathan a Senior Investigator at TGen.
Related from Yumafrogs: Will economy give us a break in 2009?
